The latest pancreatic cancer news
Study identifies mutations linked to familial pancreatic cancer
Pancreatic cancer is one of the deadliest cancers with limited treatment options. It typically comes…
Browsing: Pancreatic Cancer
Research advances to better target debilitating effects of cachexia syndrome
A study published in Cell Reports Aug. 6 describes the generation of a new mouse model developed…
Deciphering pancreatic cancer’s invade and evade tactics
Two known gene mutations induce pathways that enhance pancreatic cancer’s ability to invade tissues and…
ASCO 2019: The eight biggest stories on anticancer agents
Here is ecancer’s speedy recap on the presentations from the 2019 American Society of Clinical…
‘Promising’ antibody therapy extends survival in mice with pancreatic cancer
Scientists have found a way to target and knock out a single protein that they…
Test shown to improve accuracy in identifying precancerous pancreatic cysts
In a proof-of-concept study, an international scientific team led by Johns Hopkins Kimmel Cancer Center…
New research gives hope in the fight against pancreatic cancer
Mariano Barbacid, Centro Nacional de Investigaciones Oncológicas CNIO Pancreatic ductal adenocarcinoma (PDAC), the most common…
Long thought harmless, a glycan biomarker may cause pancreatic disease and cancer
A widely recognised biomarker for pancreatic disease, CA19-9, thought to be benign for decades, may…
ASCO 2019: Maintenance therapy with PARP inhibitor olaparib delays progression of BRCA-related pancreatic cancer
The randomised, phase III POLO trial found that maintenance therapy with the PARP inhibitor olaparib…
Pancreatic cancer specialist explains challenges of the disease and treatment advances
Nathan Bahary, University of Pittsburgh With Alex Trebek’s recent announcement that his pancreatic cancer is…